Kexing Biopharm Co., Ltd. (SHA:688136)

China flag China · Delayed Price · Currency is CNY
30.20
-0.32 (-1.05%)
At close: Feb 13, 2026
Market Cap5.98B +76.9%
Revenue (ttm)1.52B +14.2%
Net Income125.57M
EPS0.62
Shares Out198.11M
PE Ratio48.73
Forward PE48.32
Dividend0.08 (0.26%)
Ex-Dividend Daten/a
Volume1,920,810
Average Volume3,099,877
Open30.52
Previous Close30.52
Day's Range30.20 - 30.84
52-Week Range18.53 - 63.99
Beta0.80
RSI35.73
Earnings DateMar 28, 2026

About Kexing Biopharm

Kexing Biopharm Co., Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of recombinant protein drugs and microecological preparations in China, the European Union, Brazil, the Philippines, and Indonesia. The company focuses on oncology, immunology, and degenerative diseases; and develops new antibodies, proteins, nucleic acid drugs, and antiviral therapy, as well as for the treatment of tumor, autoimmune, metabolic diseases, and other therapeutic fields. It also develops GB05 human interferon a1b in... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 971
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688136
Full Company Profile

Financial Performance

Financial Statements